An interventional study of nutritional supplement and individualized nutritional guidelines in Malnutrition, sponsored by Philipp Schuetz. Recruiting at 18 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-20.
Sponsored by Philipp Schuetz · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Malnutrition with a site in Switzerland — 6 open to participants now, 6 under way, 1 of them phase 3. Malnutrition · Switzerland.
Among the 25 studies in Malnutrition with a site in Switzerland, this one is the 2nd largest by planned enrollment of the 16 interventional ones that give a count, is one of 4 that started in 2021, is one of 10 with no phase, and was the 16th registered.
1,278 studies on the registry are indexed under Malnutrition; 231 are open to participants now.
Browse Malnutrition studies →6 of the 25 studies in Malnutrition with a site in Switzerland are open now. Recruiting first, the newest first:
Philipp Schuetz · Sites in Switzerland
Ages 60+
Patrizia D'Amelio · Sites in Switzerland
Ages 75+
HEIDEGGER CP · Sites in Switzerland
Ages 18+
Centre Hospitalier Universitaire Vaudois · Sites in Switzerland
Ages 18+
Kantonsspital Winterthur KSW · Sites in Switzerland
Ages 18–100
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 150 Malnutrition studies recruiting now, 84 (56%) set no upper age limit and 44 (29%) stop at 75 or younger; 40 take children under 18; 30 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 4 started in 2021.
This study's planned enrollment of 1,200 is above the median of 119 across 844 interventional studies indexed under Malnutrition.
Median enrollment 154 across the 16 interventional studies, 139 across the 9 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 25 have an industry lead sponsor. The 10 most frequent:
Philipp Schuetz is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Philipp Schuetz has 2 studies filed under Malnutrition — fewer than ten, so there is no comparison to draw.
2 of the studies in Malnutrition with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04926597Philipp SchuetzEffect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery | 2026-12 |
| NCT06826105Philipp SchuetzPancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO) | 2027-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 25 studies in Malnutrition with a site in Switzerland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study is to compare the sustained post-discharge nutritional support to reach individual energy and protein goals to usual care home nutrition in medical patients at nutritional risk.
Malnutrition is a strong and independent long-term risk factor for mortality, rehospitalisation and functional decline, particularly in the elderly, polymorbid medical patient population. The randomized-controlled Effect of early nutritional support on Frailty, Functional Outcomes and Recovery of malnourished medical inpatients Trial (EFFORT, Lancet 2019) included 2028 patients in eight Swiss hospitals and found that nutritional support during the inhospital stay reduces very efficiently the risk for complications and mortality with numbers needed to treat (NNT) of 23 and 37, respectively.
Yet, the nutritional intervention was not continued after hospital discharge of patients and long-term follow-up data of patients showed a lack of sustained effect of the initial nutritional support strategy. There is a current lack of trial data investigating whether long-term use of nutritional support has a sustained effect on clinical outcomes in this patient population. This study is to compare the continuous use of nutritional support with the use of approved oral nutritional supplements to reach protein and energy goals and to analyze whether medical patients at nutritional risk show a sustained benefit from long-term nutritional support after hospital discharge, and why and how nutritional support affects the course of disease from a mechanistic physio-pathological standpoint.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group patients will receive individualized nutritional support to reach energy and protein goals with the support of an experienced, unblinded dietician and with use of oral nutritional supplements (ONS) as needed
Dietary Supplement: nutritional supplement · Other: individualized nutritional guidelines
Control group patients will receive nutritional counselling (general information on healthy food habits) at discharge, but no nutritional support strategy will be used during follow-up
Other: general nutritional information
daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).
nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.
general information about health food behavior upon hospital discharge
time to death from any cause (i.e., all-cause mortality)
time to death from any cause (i.e., all-cause mortality)
Time frame: Enrollment to 3 years
Time to non-elective hospital readmission after discharge from the index hospital stay
Time to non-elective hospital readmission after discharge from the index hospital stay
Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]
Time to the first major complication
time to the first major complication including death, bacterial infection with need for antibiotic treatment, major cardiovascular event (i.e., stroke, intracranial bleeding, cardiac arrest, myocardial infarction) or pulmonary embolism, acute renal failure, gastro-intestinal events (including hemorrhage, intestinal perforation, acute pancreatitis)
Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]
Changes in functional status measured by the Barthel's index
Changes in functional status measured by the Barthel's index (scores range from 0 to 100, with higher scores indicating better functional status)
Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]
Changes in quality of life measured with the European Quality of Life 5 Dimensions index (German Version, EQ-5D index)
Changes in quality of life measured with the European Quality of Life 5 Dimensions index (German Version, EQ-5D index values range from 0 to 1, with higher scores indicating better quality of life)
Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]
Changes in quality of life measured with the visual-analogue scale (EQ-5D VAS)
Changes in quality of life measured with the visual-analogue scale (EQ-5D VAS) (scores range from 0 to 100, with higher scores indicating better health status).
Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]
Change in body weight
Change in body weight
Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits
Change in calf circumference to assess muscle mass
Change in calf circumference to assess muscle mass
Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits
Change in bioelectrical impedance analysis (BIA) to assess body composition
Change in bioelectrical impedance analysis (BIA) to assess body composition
Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits
Change in hand grip by means of handgrip strength through dynamometry (North Coast Medical Exacta™ Hydraulic Hand Dynamometer) to assess muscle strength
Change in hand grip by means of handgrip strength through dynamometry (North Coast Medical Exacta™ Hydraulic Hand Dynamometer) to assess muscle strength
Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Started Aug 2021 (actual). Primary completion is estimated for Dec 2026, 64 months after the start.
Of 393 non-industry interventional studies with no phase under Malnutrition, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 64 months is above that.
Counting every sponsor, half of 419 studies reached it within 22 months; a quarter within 11 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.